Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4155/bio-2021-0078 http://scihub22266oqcxt.onion/10.4155/bio-2021-0078 34289741!8297542!34289741     free     free     free       Bioanalysis 2021 ; 13 (15): 1213-1223 Nephropedia Template TP {{tp|p=34289741|t=2021. Detection of SARS-CoV-2 at the point of care |pdf=|usr=}}{{34289741}} gab.com Text Detection of SARS-CoV-2 at the point of care JO: Bioanalysis http://www.kidney.de/pget.php?&tw=1&pmid=34289741 #FOAvip Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of COVID-19. Testing for SARS-CoV-2 infection is a critical element of the public health response to COVID-19. Point-of-care (POC) tests can drive patient management decisions for infectious diseases, including COVID-19. POC tests are available for the diagnosis of SARS-CoV-2 infections and include those that detect SARS-CoV-2 antigens as well as amplified RNA sequences. We provide a review of SARS-CoV-2 POC tests including their performance, settings for which they might be used, their impact and future directions. Further optimization and validation, new technologies as well as studies to determine clinical and epidemiological impact of SARS-CoV-2 POC tests are needed. Twit Text FOAVip Detection of SARS-CoV-2 at the point of care ????Bioanalysis http://www.kidney.de/pget.php?&tw=1&pmid=34289741 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34289741 #FOAvip English Wikipedia <ref>{{Cite pmid|34289741}}</ref> Detection of SARS-CoV-2 at the point of care #MMPMID34289741 Loeffelholz MJ; Tang YW Bioanalysis 2021[Aug]; 13 (15): 1213-1223 PMID34289741show ga Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of COVID-19. Testing for SARS-CoV-2 infection is a critical element of the public health response to COVID-19. Point-of-care (POC) tests can drive patient management decisions for infectious diseases, including COVID-19. POC tests are available for the diagnosis of SARS-CoV-2 infections and include those that detect SARS-CoV-2 antigens as well as amplified RNA sequences. We provide a review of SARS-CoV-2 POC tests including their performance, settings for which they might be used, their impact and future directions. Further optimization and validation, new technologies as well as studies to determine clinical and epidemiological impact of SARS-CoV-2 POC tests are needed. |COVID-19/*diagnosis/pathology[MESH] |Humans[MESH] |Point-of-Care Systems/*standards[MESH]Detection of SARS-CoV-2 at the point of care (epmc).pdf DeepDyve Pubget Overpricing